Acuitas, Partner CureVac Settle Clash Over Vaccine-Tech Patents
Acuitas Therapeutics Inc. and CureVac NV have settled their clash over who controls patents central to a blockbuster Covid-19 shot, according to filings in Virginia federal court.
Acuitas Therapeutics Inc. and CureVac NV have settled their clash over who controls patents central to a blockbuster Covid-19 shot, according to filings in Virginia federal court.
Paul Weiss has been stymied in its effort to open a Houston office, as top equity partners at rival firms spurned recruitment efforts.
The Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.
Fragments of the bird flu virus have been found in about one fifth of commercial milk samples tested in a US nationally representative study, according to the Food and Drug Administration.
A Chicago safety-net hospital can proceed with its lawsuit alleging the state Medicaid department failed to ensure that managed care organizations promptly paid providers, a divided federal appeals court said Thursday.
A federal judge rejected
A federal judge in Ohio delivered a split decision in a contract dispute between a firm that helps health-care providers recover underpayments from insurers and one of its former clients.
Mallinckrodt Plc, which used Chapter 11 to resolve opioid liability, doesn’t have to pay royalty payments on a lucrative drug, an appellate court said.
Alpha Brain supplements made by Onnit Labs Inc. were deceptively marketed as supporting memory, focus, and mental processing speed because the claims were based on a flawed clinical study, a new class action alleges.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: